Detalles de la búsqueda
1.
Optimized dose selective HDAC inhibitor tucidinostat overcomes anti-PD-L1 antibody resistance in experimental solid tumors.
BMC Med
; 20(1): 435, 2022 Nov 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-36352411
2.
Treatment-related adverse events of PD-1 and PD-L1 inhibitor-based combination therapies in clinical trials: a systematic review and meta-analysis.
Lancet Oncol
; 22(9): 1265-1274, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34391508
3.
Dynamics of peripheral T cell clones during PD-1 blockade in non-small cell lung cancer.
Cancer Immunol Immunother
; 69(12): 2599-2611, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32591861
4.
A novel tumor mutational burden estimation model as a predictive and prognostic biomarker in NSCLC patients.
BMC Med
; 18(1): 232, 2020 08 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-32843031
5.
Metabolic Mechanisms and a Rational Combinational Application of Carboxyamidotriazole in Fighting Pancreatic Cancer Progression after Chemotherapy.
J Pharmacol Exp Ther
; 367(1): 20-27, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30002095
6.
CD74/SLC34A2-ROS1 Fusion Variants Involving the Transmembrane Region Predict Poor Response to Crizotinib in NSCLC Independent of TP53 Mutations.
J Thorac Oncol
; 19(4): 613-625, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38070598
7.
Treatment of advanced non-small cell lung cancer with driver mutations: current applications and future directions.
Front Med
; 17(1): 18-42, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36848029
8.
Abnormal activation of NF-κB and MAPK signaling pathways affect osimertinib resistance and influence the recruitment of myeloid-derived suppressor cells to shape the immunosuppressive tumor immune microenvironment.
Thorac Cancer
; 14(19): 1843-1856, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37221702
9.
Multi-omics indicators of long-term survival benefits after immune checkpoint inhibitor therapy.
Cell Rep Methods
; 3(10): 100596, 2023 Oct 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-37738982
10.
Development and validation of a nomogram based on preoperative variables for predicting recurrence-free survival in stage IA lung adenocarcinoma.
Thorac Cancer
; 14(31): 3108-3118, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37793977
11.
Effectiveness of neoadjuvant immunochemotherapy compared to neoadjuvant chemotherapy in non-small cell lung cancer patients: Real-world data of a retrospective, dual-center study.
Front Oncol
; 13: 1145303, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37064108
12.
A prognostic and immunotherapeutic predictive model based on the cell-originated characterization of tumor microenvironment in lung adenocarcinoma.
iScience
; 26(5): 106616, 2023 May 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-37168563
13.
Ablation of ERO1A induces lethal endoplasmic reticulum stress responses and immunogenic cell death to activate anti-tumor immunity.
Cell Rep Med
; 4(10): 101206, 2023 10 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-37769655
14.
Effect of dexmedetomidine on postoperative systemic inflammation and recovery in patients undergoing digest tract cancer surgery: A meta-analysis of randomized controlled trials.
Front Oncol
; 12: 970557, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36185178
15.
Genomic and epigenomic profiles distinguish pulmonary enteric adenocarcinoma from lung metastatic colorectal cancer.
EBioMedicine
; 82: 104165, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-35901658
16.
Single-cell transcriptomic profiling reveals the tumor heterogeneity of small-cell lung cancer.
Signal Transduct Target Ther
; 7(1): 346, 2022 10 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36195615
17.
Metagenome association study of the gut microbiome revealed biomarkers linked to chemotherapy outcomes in locally advanced and advanced lung cancer.
Thorac Cancer
; 12(1): 66-78, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33111503
18.
TP53 mutations in circulating tumor DNA in advanced epidermal growth factor receptor-mutant lung adenocarcinoma patients treated with gefitinib.
Transl Oncol
; 14(9): 101163, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-34192651
19.
Weighting tumor-specific TCR repertoires as a classifier to stratify the immunotherapy delivery in non-small cell lung cancers.
Sci Adv
; 7(21)2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34138742
20.
Influence of adjuvant chemotherapy on survival for patients with stage IB and IIA non-small cell lung cancer.
Thorac Cancer
; 12(1): 30-39, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33111432